Huntsman Corporation
NYSE:HUNChemicals
-$0.46 today
- Market cap
- $1.58B
- Beta
- 0.66
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.87
- Dividend yield
- 4.18%
Volume 3.62M
Average 5.21M
HUN Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Huntsman CorporationNYSE: HUN
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 10.5% from a year ago
Cash & equivalents stood at $369M at the end of Q1 FY2026, up 10.5% from a year earlier and down 14.0% from the prior quarter. Over 3 fiscal years it compounded at -13.1% a year.
Context
- Cash & equivalents amounted to 5.2% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +10.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 429M USD
- Year-over-year change
- +26.2%
- 4-year CAGR
- -19.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 429M | +26.2% |
| FY2024 | 2024-12-31 | 340M | -37.0% |
| FY2023 | 2023-12-31 | 540M | -17.4% |
| FY2022 | 2022-12-31 | 654M | -37.2% |
| FY2021 | 2021-12-31 | 1.04B | — |
Cash & Equivalents vs competitors
How HUN compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +10.5% is the 8th highest of 11, against a peer median of +102.5%.
- Cash & equivalents amounts to 5.2% of total assets for HUN, versus a peer median of 29.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | R$4.62B BRL | -59.2% | -5.6% | 6.2% | |
| Mar 2026 | $1.21B USD | +171.3% | +863.1% | 38.8% | |
| Jun 2026 | $671M USD | +33.7% | -15.2% | 9.4% | |
| Jan 2026 | CA$503.76M CAD | +299.4% | +63.2% | 49.3% | |
| Mar 2026 | $421.99M USD | +15.9% | +42.5% | 28.8% | |
| Mar 2026 | $369M USD | +10.5% | -13.1% | 5.2% | |
| Mar 2026 | $207.35M USD | +270.5% | +392.6% | 35.3% | |
| Jun 2026 | $130.72M USD | +7.2% | +15.9% | 7.0% | |
| Dec 2025 | $80.92M USD | +54036.8% | +91.0% | 30.3% | |
| Dec 2025 | $65.83M USD | -14.7% | +113.0% | 51.0% | |
| Jun 2026 | $58.5M USD | +346.6% | -50.4% | 2.0% | |
| Peer median (excluding HUN) | — | +102.5% | +52.9% | 29.5% | |
Competitors are the stored peer set for HUN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.04B | 654M | 540M | 340M | 429M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.35B | 834M | 753M | 725M | 677M |
| Inventory | 1.04B | 995M | 867M | 917M | 818M |
| Other Current Assets | 501M | 662M | 62M | 29M | 46M |
| Total Current Assets | 3.93B | 3.15B | 2.31B | 2.13B | 2.06B |
| Property, Plant & Equipment (Net) | 2.82B | 2.75B | 2.74B | 2.88B | 2.85B |
| Goodwill | 650M | 641M | 644M | 633M | 630M |
| Intangible Assets | 469M | 425M | 387M | 344M | 308M |
| Long-term Investments | 470M | 425M | 438M | 346M | 309M |
| Tax Assets | 180M | 147M | 112M | 69M | 49M |
| Other Non-current Assets | 871M | 686M | 611M | 722M | 804M |
| Total Non-current Assets | 5.46B | 5.08B | 4.93B | 4.99B | 4.95B |
| Total Assets | 9.39B | 8.22B | 7.25B | 7.11B | 7.02B |
| Account Payables | 1.11B | 961M | 719M | 770M | 721M |
| Short-term Debt | 12M | 66M | 12M | 325M | 410M |
| Tax Payables | 184M | 112M | 116M | 117M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 163M | 194M | 0 | 338M | 349M |
| Total Current Liabilities | 2.05B | 1.7B | 1.17B | 1.57B | 1.59B |
| Long-term Debt | 1.54B | 1.67B | 1.68B | 1.51B | 1.99B |
| Deferred Tax Liabilities | 161M | 250M | 243M | 204M | 156M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 737M | 422M | 345M | 324M | (11M) |
| Total Non-current Liabilities | 2.78B | 2.68B | 2.6B | 2.39B | 2.47B |
| Total Liabilities | 4.83B | 4.38B | 3.77B | 3.95B | 4.06B |
| Common Stock | 3M | 3M | 3M | 3M | 3M |
| Retained Earnings | 2.44B | 2.71B | 2.62B | 2.25B | 1.81B |
| Accumulated OCI | (1.2B) | (1.27B) | (1.25B) | (1.2B) | (1.01B) |
| Other Stockholders Equity | (25M) | (35M) | (41M) | (32M) | (28M) |
| Minority Interest | 181M | 216M | 227M | 204M | 207M |
| Total Equity | 4.56B | 3.84B | 3.48B | 3.16B | 2.96B |
| Total Debt | 1.95B | 2.12B | 2.07B | 2.24B | 2.73B |
| Net Debt | 904M | 1.47B | 1.53B | 1.9B | 2.31B |
Huntsman Corporation
NYSE:HUN
Intrinsic Alpha fair value
Locked
Current Price
$9.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.